Effects of the ruthenium-based drug NAMI-A on the roles played by TGF-β1 in the metastatic process
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of the ruthenium-based drug NAMI-A on the roles played by TGF-β1 in the metastatic process
Authors
Keywords
Anticancer drug, Heavy metal, Biomedicine, Molecular dynamics
Journal
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
Volume 20, Issue 7, Pages 1163-1173
Publisher
Springer Nature
Online
2015-09-14
DOI
10.1007/s00775-015-1297-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway
- (2014) Xavier Catteau et al. BMC CANCER
- Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
- (2014) Suzanne Leijen et al. INVESTIGATIONAL NEW DRUGS
- NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
- (2014) Robert Trondl et al. Chemical Science
- Management of Fibrosis: The Mesenchymal Stromal Cells Breakthrough
- (2014) Benoît Usunier et al. Stem Cells International
- Microenvironment and tumor cell plasticity: An easy way out
- (2013) Maria Letizia Taddei et al. CANCER LETTERS
- The molecular composition of the metastatic niche
- (2013) Arnaud Descot et al. EXPERIMENTAL CELL RESEARCH
- EPR as a probe of the intracellular speciation of ruthenium(iii) anticancer compounds
- (2013) Michael I. Webb et al. Metallomics
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Tumor and its microenvironment: A synergistic interplay
- (2013) Veronica Catalano et al. SEMINARS IN CANCER BIOLOGY
- Critical Role of Transforming Growth Factor Beta in Different Phases of Wound Healing
- (2013) Mohammadreza Pakyari et al. Advances in Wound Care
- CDK1 Hyperphosphorylation Maintenance Drives the Time-course of G2-M Cell Cycle Arrest after Short Treatment with NAMI-A in Kb Cells
- (2012) Alberta Bergamo et al. Anti-Cancer Agents in Medicinal Chemistry
- From Conventional to Unusual Enzyme Inhibitor Scaffolds: The Quest for Target Specificity
- (2011) Eric Meggers ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Approaching tumour therapy beyond platinum drugs
- (2011) A. Bergamo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis
- (2011) Yvette Drabsch et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Ruthenium-based chemotherapeutics: are they ready for prime time?
- (2010) Emmanuel S. Antonarakis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Transforming growth factor-β and the hallmarks of cancer
- (2010) Maozhen Tian et al. CELLULAR SIGNALLING
- Ruthenium versus platinum: interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry
- (2010) Michael Groessl et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Roles of GRP78 in physiology and cancer
- (2010) Lu-Hua Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Organometallic ruthenium-based antitumor compounds with novel modes of action
- (2010) Wee Han Ang et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- A Ruthenium-Containing Organometallic Compound Reduces Tumor Growth through Induction of the Endoplasmic Reticulum Stress Gene CHOP
- (2009) Xiangjun Meng et al. CANCER RESEARCH
- Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs
- (2009) Sabine H. van Rijt et al. DRUG DISCOVERY TODAY
- Recent developments in ruthenium anticancer drugs
- (2009) Aviva Levina et al. Metallomics
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now